AMRI And Cystic Fibrosis Foundation Launch Major Research Collaboration
AMRI (NASDAQ: AMRI) and the Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit affiliate of the Cystic Fibrosis Foundation, announced a four-year research collaboration, worth up to $23.7 million, aimed at identifying novel treatments that address the core defect in cystic fibrosis.
